Patients With STEMI Without Standard Modifiable Risk Factors.
作者信息
Mizori Rasi, Ijaz Mueed, Ahmad Malik Takreem, Sadiq Muhayman, Ahmad Mahmood
机构信息
GKT School of Medical Education, King's College London, London, United Kingdom.
Tahir Heart Institute, Rabwah, Pakistan.
出版信息
JACC Asia. 2024 Apr 30;4(6):500. doi: 10.1016/j.jacasi.2024.02.005. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Patients With STEMI Without Standard Modifiable Risk Factors.无标准可改变危险因素的ST段抬高型心肌梗死患者
JACC Asia. 2024 Apr 30;4(6):500. doi: 10.1016/j.jacasi.2024.02.005. eCollection 2024 Jun.
2
Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors.有或无标准可改变心血管危险因素的急性心肌梗死患者死亡率结局的比较
Front Cardiovasc Med. 2022 Apr 14;9:876465. doi: 10.3389/fcvm.2022.876465. eCollection 2022.
3
Prevalence and Outcomes in STEMI Patients Without Standard Modifiable Cardiovascular Risk Factors: A National Inpatient Sample Analysis.无标准可调节心血管风险因素的 STEMI 患者的流行率和结局：全国住院患者样本分析。
Curr Probl Cardiol. 2022 Nov;47(11):101343. doi: 10.1016/j.cpcardiol.2022.101343. Epub 2022 Aug 5.
4
Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factors.无标准可调节危险因素的 ST 段抬高型心肌梗死患者的临床转归。
J Cardiol. 2024 Jul;84(1):41-46. doi: 10.1016/j.jjcc.2023.11.007. Epub 2023 Dec 2.
5
Trends and Outcomes of ST-Segment-Elevation MI in Hospitalized Patients Without Standard Modifiable Cardiovascular Risk Factors.无标准可调节心血管风险因素的住院 ST 段抬高型心肌梗死患者的趋势和结局。
Curr Probl Cardiol. 2022 Sep;47(9):101271. doi: 10.1016/j.cpcardiol.2022.101271. Epub 2022 May 26.
6
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.越来越多的 ST 段抬高型心肌梗死患者的冠状动脉粥样硬化程度不能用标准的可改变的危险因素来很好地解释。
Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830. doi: 10.1177/2047487317720287. Epub 2017 Jul 13.
7
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率：SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.
8
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?无标准可调节心血管风险因素的 ST 段抬高型心肌梗死（STEMI）患者——他们有多常见，其结局如何？
J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1.
9
Differences in treatment and outcomes among patients with ST-segment elevation myocardial infarction with and without standard modifiable risk factors: a systematic review and meta-analysis.伴有和不伴有标准可改变危险因素的ST段抬高型心肌梗死患者在治疗和结局方面的差异：一项系统评价和荟萃分析
Ann Med Surg (Lond). 2023 May 3;85(6):2916-2923. doi: 10.1097/MS9.0000000000000738. eCollection 2023 Jun.
10
Smoking is the dominating modifiable risk factor in younger patients with STEMI.吸烟是年轻 STEMI 患者中主要的可改变的危险因素。
Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):70-75. doi: 10.1177/2048872618810414. Epub 2018 Nov 2.
引用本文的文献
1
Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.中东动脉粥样硬化性心血管疾病患者缺乏标准可改变风险因素。约旦缺乏标准可改变风险因素（SMuRF-Less）研究。
Vasc Health Risk Manag. 2025 Feb 5;21:39-50. doi: 10.2147/VHRM.S499355. eCollection 2025.
本文引用的文献
1
Characteristics, Treatment, and In-Hospital Outcomes of Older Patients With STEMI Without Standard Modifiable Risk Factors.无标准可改变危险因素的老年ST段抬高型心肌梗死患者的特征、治疗及住院结局
JACC Asia. 2023 Nov 21;4(1):73-83. doi: 10.1016/j.jacasi.2023.09.013. eCollection 2024 Jan.
2
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.无传统可调节危险因素的患者的冠状动脉粥样硬化临床路径：JACC 现状评价。
J Am Coll Cardiol. 2023 Sep 26;82(13):1343-1359. doi: 10.1016/j.jacc.2023.06.045.
3
Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and ≥ 1 SMuRF ACS cases: an analysis of 15,051 cases from Pakistan.无标准可调节风险因素（SMuRFless）与≥1 个 SMuRF ACS 病例之间的临床特征、管理和 5 年生存率比较：来自巴基斯坦的 15051 例分析。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):320. doi: 10.1186/s12872-023-03355-z.
Zotero 插件